Cargando…
Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1
Human IL-1 was successfully used to produce an anti-IL-1 mAb. Anti-IL-1 (IgG2a) blocked IL-1-mediated thymocyte and fibroblast proliferation, but did not interfere with the biological effects of other lymphokines, such as IL-2 or IL-3. The antibody immunoprecipitated biosynthetically radiolabeled 33...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188039/ https://www.ncbi.nlm.nih.gov/pubmed/2418147 |
Ejemplares similares
-
Monoclonal antibodies directed against the sexual binding site of Chlamydomonas eugametos gametes
Publicado: (1988) -
Commentary: Production and Characterization of Monoclonal Antibodies to Human Interleukin 2: Strategy and Tactics
por: Smith, Kendall A.
Publicado: (2015) -
Development and Characterization of New Monoclonal Antibodies Against Porcine Interleukin-17A and Interferon-Gamma
por: Manirarora, Jean N., et al.
Publicado: (2022) -
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
por: Liu, Ling, et al.
Publicado: (2016) -
Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor
Publicado: (1990)